Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn't produce enough insulin or i ...

Throughout it all, one of Abbott Laboratories' segments has been its best and most consistent growth driver: Diabetes care. Abbott Labs recently added a new product to this business that could ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Summary. In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

The first step to dealing with this new reality in your life is to realize that there are a lot of resources and support ...

Five surprising things that raise your risk of Type 2 diabetes The 28 Biggest '00s Fashion Icons Northern Lights set to be ...